Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer.
Burtness B, Gibson M, Egleston B, Mehra R, Thomas L, Sipples R, Quintanilla M, Lacy J, Watkins S, Murren JR, Forastiere AA.
Burtness B, et al. Among authors: quintanilla m.
Ann Oncol. 2009 Jul;20(7):1242-8. doi: 10.1093/annonc/mdn787. Epub 2009 May 8.
Ann Oncol. 2009.
PMID: 19429872
Free PMC article.
Clinical Trial.